MISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) announced today financial results for the three months ended December 31, 2010. The Company reported a net loss of approximately $7,620,000, or $0.13 per share, which includes a non-cash charge of approximately $7,202,000 related to increases in the fair value of warrants that are included as a component of other income (expenses) in the statement of operations, for the three months ended December 31, 2010, compared to a net loss of $15,276,000, or $0.33 per share, which includes a non-cash charge of approximately $13,860,000 related to increases in the fair value of warrants that are included as a component of other income (expenses) in the statement of operations, for the three months ended December 31, 2009.
